News from our Partners and Qualified Vendors – Q1 2022

ConsilX has been listed in the 101 Top Southeast Asia Pharmaceutical Companies and Startups ranking. 2GL recently opened the new entity in Skopje, Macedonia. Advice Pharma has started a strong partnership in the management of international biobanking services with an international biobanking company BioRep S.r.l. (a Sapio Group company). ​​​​​​​Phoenix Clinical Research opened a new […]

SIRO Clinpharm partners with ACROSS Global Alliance

SIRO Clinpharm, a CRO in India announced that they have become a partner of ACROSS Global Alliance (ACROSS) and will help represent India in working towards the common goals and objectives of ACROSS in bridging a gap in the pharma service provider market. ACROSS is a global alliance of clinical research organisations (CROs) also known […]

Contributed: Trials and tribulations – the new world of decentralized trials

Asset Management Ventures’ Skip Fleshman outlines COVID-19’s impact on clinical trials and the resulting leap toward tech-enabled decentralized trials. Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective. […]

2-day QMS Workshop in Riga

An ACROSS Global™2-day QMS Workshop was held in Riga, Latvia from 12-13 September 2019. Quality Assurance Representatives from ACROSS member companies included Steven Bukvic (Chairman, Executive Committee – ACROSS Global; Chief Strategy Officer – Synergy CRO), Josipa Ljubičić (Head of QA Department -Marti Farm), Rossella De Paola (QA Assistant – MTA SocialMedia ) and BANU […]

Tech trends in Pharmaceuticals and Healthcare industries in Q2 2019/Part III

The most promising areas of tech disruption in Pharmaceuticals and Healthcare industries are Patient-faced services and new tech for Clinical trials and Healthcare providers.   HEALTHCARE PROVIDERS   Data Integration Healthcare data integration platform Innovaccer announced that it has raised an additional $10 million in funding, boosting its Series B funding round up to $35 million. The […]

Tech trends in Pharmaceuticals and Healthcare industries in Q2 2019/Part II

Now there is a time for streamlined tech disruption everywhere. Pharmaceuticals and Healthcare industries aren’t exceptions from this global trend, but strong state authorities’ regulation in these areas makes plenty of difficulties for tech startups aiming to improve the efficiency of patient-to-service transaction processes. Nevertheless, beginning from early 2012, there are tens of ambitious and […]

Tech trends in Pharmaceuticals and Healthcare industries in Q2 2019/ Part I

Now there is a time for streamlined tech disruption everywhere. Pharmaceuticals and Healthcare industries aren’t exceptions from this global trend, but strong state authorities’ regulation in these areas makes plenty of difficulties for tech startups aiming to improve the efficiency of patient-to-service transaction processes. Nevertheless, beginning from early 2012, there are tens of ambitious and […]

ACROSS Global launched its first edition of the “CAR T-Cell Therapy Paper”

6-June-2019: ACROSS Global launched its first edition of the “CAR T-Cell Therapy Paper”. A bi-annual, open-access online paper covering CAR T-Cell Therapy. The journal covers a broad range of CAR T-Cell topics compiled from a variety of publicly available sources. The journal presents the reader with up-to-date news, NDA approvals, data trends, changes in global […]

We Will Be Speaking in Boston Soon

Igor Stefanov, Kingsman @ ACROSS and CEO @ Synergy will speak at the Clinically Validated Digital Therapeutics Summit 2018, Boston, 3-4 December. The Clinically Validated Digital Therapeutics Summit is the platform for pharma digital innovators, DTx trailblazers and healthcare pioneers to advance the translation, application and commercialization of evidence-based, robustly validated digital therapeutics. http://www.clinicallyvalidated-dtx.com/

  1. Pages:
  2. 1
  3. 2